Rheumatoid arthritis: Diagnose early and treat to target

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

New treatments have multiplied in the last three decades that improve rheumatologists' capabilities for altering and even controlling RA. More recently, we have recognized that new approaches to providing these discoveries will also be required if RA patients are to realize their benefits, including: Early diagnosis and early treatment, Sensitive and practical RA disease activity measurements to direct treatment, Accelerating treatment until inflammation in the joints and other tissues is controlled, known in our field as Treating to Target, and Providing personalized patient care, because RA is variable from one patient to another. Not only do responses to treatment and side effects vary, but patients differ in their preferences and priorities for disease management.

Original languageEnglish (US)
Title of host publicationGreat Health Care
Subtitle of host publicationMaking It Happen
PublisherSpringer US
Pages123-136
Number of pages14
Volume9781461411987
ISBN (Electronic)9781461411987
ISBN (Print)1461411971, 9781461411970
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Keywords

  • CDAI
  • Diagnose early
  • Disease activity measurement
  • DMARD
  • GAS
  • Personalized medicine
  • RAPID3
  • Rheumatoid arthritis-
  • Treat aggressively
  • Treat to target

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Rheumatoid arthritis: Diagnose early and treat to target'. Together they form a unique fingerprint.

  • Cite this

    Cush, J. J. (2012). Rheumatoid arthritis: Diagnose early and treat to target. In Great Health Care: Making It Happen (Vol. 9781461411987, pp. 123-136). Springer US. https://doi.org/10.1007/978-1-4614-1198-7_15